Publicaciones en las que colabora con MARÍA DOLORES FOLGUEIRA LÓPEZ (17)

2022

  1. A predictive score at admission for respiratory failure among hospitalized patients with confirmed 2019 Coronavirus Disease: a simple tool for a complex problem

    Internal and Emergency Medicine, Vol. 17, Núm. 2, pp. 515-524

  2. Cytomegalovirus Exposure and the Risk of Overall Infection After Kidney Transplantation: A Cohort Study on the Indirect Effects Attributable to Viral Replication

    Transplant International, Vol. 35

  3. Genetic polymorphisms in TLR3, IL10 and CD209 influence the risk of BK polyomavirus infection after kidney transplantation

    Scientific Reports, Vol. 12, Núm. 1

  4. Role of cytomegalovirus infection after kidney transplantation on the subsequent risk of atherosclerotic and thrombotic events

    Atherosclerosis Plus, Vol. 48, pp. 37-46

2021

  1. Impact of late-onset cytomegalovirus infection in the development of cardiac allograft vasculopathy in heart transplant recipients

    Transplant Infectious Disease, Vol. 23, Núm. 2

2020

  1. COVID-19 in solid organ transplant recipients: A single-center case series from Spain

    American Journal of Transplantation, Vol. 20, Núm. 7, pp. 1849-1858

  2. Incidence and clinical profiles of COVID-19 pneumonia in pregnant women: A single-centre cohort study from Spain

    EClinicalMedicine, Vol. 23

  3. Monitoring of CMV-specific cell-mediated immunity with a commercial ELISA-based interferon-γ release assay in kidney transplant recipients treated with antithymocyte globulin

    American Journal of Transplantation, Vol. 20, Núm. 8, pp. 2070-2080

2018

  1. Experience with leflunomide as treatment and as secondary prophylaxis for cytomegalovirus infection in lung transplant recipients: A case series and review of the literature

    Clinical Transplantation, Vol. 32, Núm. 2

2016

  1. Detection of Epstein–Barr virus DNAemia after lung transplantation and its potential relationship with the development of post-transplant complications

    Transplant Infectious Disease, Vol. 18, Núm. 3, pp. 431-441

2015

  1. Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey

    Clinical Microbiology and Infection, Vol. 21, Núm. 6, pp. 604.e1-604.e9

  2. Influence of cytomegalovirus infection in the development of cardiac allograft vasculopathy after heart transplantation

    Journal of Heart and Lung Transplantation, Vol. 34, Núm. 8, pp. 1112-1119

2013

  1. Limited impact of cytomegalovirus infection in the long-term outcome of renal and liver transplant

    Journal of Clinical Virology, Vol. 56, Núm. 4, pp. 316-322

2009

  1. Preemptive therapy is not adequate for prevention of cytomegalovirus disease in pancreas-kidney transplant recipients

    Transplant Infectious Disease, Vol. 11, Núm. 5, pp. 400-404

2007

  1. Clinical implications of respiratory virus infections in solid organ transplant recipients: A prospective study

    Transplantation, Vol. 84, Núm. 7, pp. 851-856

2006

  1. Brote nosocomial de gripe en pacientes hematológicos de alto riesgo. Eficacia de las medidas de control y del uso de zanamivir

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 24, Núm. 1, pp. 10-13

2004

  1. Eficacia del tratamiento anticipado con ganciclovir en la prevención de la enfermedad por citomegalovirus en receptores de un trasplante de hígado

    Medicina Clinica, Vol. 122, Núm. 2, pp. 41-45